The Limited Times

Now you can see non-English news...

Covid-19: new Defense Council one week before the start of the school year

2021-04-21T11:42:46.647Z


UPDATE ON THE SITUATION - New measures, new reports and highlights: an update on the latest developments in the Covid-19 pandemic around the world.


New Health Defense Council around the Head of State this Wednesday, April 21 in the morning.

One week before the start of the school year, the question of the calendar has still not been decided.

If the president has promised a reopening of terraces and certain cultural establishments in mid-May, it remains to be seen whether this deconfinement will be uniform in French territory.

To discover

  • Covid-19: instructions for use of self-tests

In addition, the European Medicines Agency, the Johnson & Johnson vaccine against Covid-19, on which many countries rely to accelerate immunization campaigns, will be able to be used in Europe, paving the way for an acceleration of campaigns. vaccination.

Read also: Covid-19: why the decline of the epidemic promises to be slower than last spring

  • New Health Defense Council

Emmanuel Macron is chairing a Health Defense Council this Wednesday morning.

The lifting of restrictions is hoped for with impatience mixed with concern by traders or restaurateurs, the latter cumulating about eight months of closure since the start of the pandemic more than a year ago.

The deconfinement schedule has not changed for the moment: elementary school students must return to class on April 26, middle and high school students on May 3.

A wider reopening is planned, including terraces of cafes and restaurants and cultural places, from mid-May.

It remains to be seen whether this confinement will be done in a uniform manner throughout the territory: in an interview with the Telegram on Tuesday, Olivier Véran evoked the track of a territorialized deconfinement.

SEE ALSO -

Covid-19: Macron welcomes the pace of vaccination but admits "difficulties" to convince on the AstraZeneca

  • Europe: green light for Johnson & Johnson vaccine

The European Medicines Agency (EMA) on Tuesday gave the green light to the Johnson & Johnson vaccine, whose use is suspended in the United States and Europe due to the rare occurrence of serious blood clots.

The European regulator has ruled that this serum, on which many countries rely to speed up immunization campaigns, could be used, due to a favorable benefit / risk ratio.

In the process, Italy announced Tuesday that it approved this vaccine and that it recommends it to people over 60 years old.

  • Netherlands: end of curfew and reopening of café terraces on April 28

Dutch Prime Minister Mark Rutte announced on Tuesday the relaxation of measures against Covid in the Netherlands, notably with a lifting of the curfew and a partial reopening of café terraces from April 28.

The January introduction of the curfew, the first in the Netherlands since World War II, sparked the worst riots in the country in decades.

  • Argentina, first Latin American country to produce Russian vaccine Sputnik V

President Alberto Fernandez welcomed Tuesday that Argentina has become the first country in Latin America to produce the Russian vaccine Sputnik V, after a transfer of technology to a private laboratory.

  • Record of more than 2,000 dead in 24 hours in India

India recorded more than 2,000 deaths from Covid-19 on Wednesday and nearly 300,000 new cases in 24 hours, which represents one of the highest daily tolls in the world since the start of the pandemic, according to official data .

Figures from the Ministry of Health indicate that 295,000 new cases have been identified in the past 24 hours, bringing the total to 15.6 million infections.

A total of 2,023 deaths have been recorded, bringing the total toll of the pandemic to 182,553 dead in the country.

SEE ALSO -

In India, crematoriums and cemeteries overcrowded by deaths from the virus

  • United States: a joint against a vaccine

'

A joint for a vaccine

': Marijuana legalization activists made a splash in Manhattan, New York on Tuesday, offering a joint to anyone who can attest to having received at least one dose of the anti-Covid vaccine.

  • AstraZeneca vaccine authorized for over 45s in Quebec

The Quebec government announced on Tuesday that it was extending the vaccination with AstraZeneca serum to people over 45 years old, previously reserved for people aged 55 and over.

Read also: Vaccines: Can the European Union do without AstraZeneca next year?

  • Spain: suspension of a regional law making vaccination compulsory

The Spanish Constitutional Court on Tuesday suspended a law taken by the authorities of the Galicia region (north-west) which required its inhabitants to be vaccinated against Covid-19.

The government had filed an appeal against this law which provided for fines of up to 3,000 euros in the event of an unjustified refusal to be vaccinated.

  • Tunisia: calls for doctors to express themselves on the Covid

The NGO Amnesty International and the Tunisian Order of Physicians have called on the government to allow practitioners to express themselves freely on the Covid-19 pandemic, after a directive requiring prior authorization for health personnel wishing to express themselves publicly on the subject.

  • Over three million dead

The pandemic caused by the new coronavirus has killed at least 3,031,441 people around the world since December 2019, according to a report established by AFP from official sources, Tuesday at 10 a.m. GMT.

The United States is the country with the highest death toll, 568,416, followed by Brazil (378,003), Mexico (212,466), India (180,530) and the United Kingdom (127,274).

These figures are globally underestimated.

They are based on daily reports from national health authorities, without including reassessments based on statistical bases.

Source: lefigaro

All tech articles on 2021-04-21

You may like

Trends 24h

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.